Dr. Jean A. Otrakji, MD

Dr. Otrakji practices at Holmdel Dialysis in Holmdel, New Jersey.

Dr. Otrakji's NPI, 1154380996, was assigned on March 21, 2006. Dr. Otrakji graduated from Damascus University Faculty of Medicine in 1972. Dr. Otrakji holds New Jersey license 25MA04735600.

Dr. Otrakji's primary practice is Holmdel Dialysis, at 668 N Beers St, Holmdel, NJ 07733 in Monmouth County. The practice phone is (732) 203-0321.

Dr. Otrakji's primary practice is Holmdel Dialysis in Holmdel, New Jersey. Dr. Otrakji is also affiliated with Bayshore Medical Center. The medical group on file is Nephrology Services Medical Group of New Jersey. Dmand AI also links Dr. Otrakji to 2 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Otrakji practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Otrakji's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Otrakji is board certified in internal medicine by the American Board of Internal Medicine. Dr. Otrakji is licensed in New Jersey.

CMS data shows 303 Medicare services from Dr. Otrakji across 2 procedure codes in 2024, for 152 Medicare patients. Medicare paid $39,565 for them. Every service was in an office.

CMS counts 152 Medicare patients who saw Dr. Otrakji in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Otrakji's median patient age at 75, with 43% women.

In 2024, Dr. Otrakji wrote 934 Medicare Part D claims for 137 patients. 96% of them were for generic drugs. CMS names the drug for 698 of them, across 25 drugs with 11 or more claims each, at $20,582 in total drug cost. In 2023, CMS named 726 claims across 25 drugs.

Dr. Otrakji accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Otrakji as offering telehealth.

CMS Open Payments shows 9 general payments to Dr. Otrakji from 6 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 98% of the total. Endologix, Inc. paid the most, $125.

Dr. Otrakji graduated from Damascus University Faculty of Medicine in 1972.